BR101801 in Adult Patients With Advanced Hematologic Malignancies(Phase I)

Clinical trial NCT04018248 · COMPLETED

Trial details

NCT number: NCT04018248
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma Follicular Lymphoma Chronic Lymphocytic Leukemia Small Lymphocytic Leukemia B Cell Lymphoma Marginal Zone Lymphoma Waldenstrom Macroglobulinemia Peripheral T Cell Lymphoma

Start date: 2020-04-21
Primary completion: 2023-09-21
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.